Engineered immune cells could transform treatment for autoimmune diseases

Immune cells that are designed to soothe could improve treatment for organ transplants, type 1 diabetes and other autoimmune conditions.

Switching from animal-based to plant-based foods reduces risk of heart disease, diabetes, and mortality

The effects of replacing animal-based foods with plant-based alternatives on cardiometabolic health and all-cause mortality.

November 20, 2023

Study uses genomic data to produce high-resolution serial interval estimates for COVID-19

Researchers developed an approach for integrating whole-genomic viral sequences and epidemiological information for serial interval (SI) estimation.

August 16, 2023

AstraZeneca’s monoclonal antibody misses primary endpoint in mid-stage trial in COPD

AstraZeneca’s anti-IL-33 monoclonal antibody failed a Phase 2a study in chronic obstructive pulmonary disease, though the company noted there were still “encouraging clinical efficacy signals

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.